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Abstract
Multicellular organisms face the necessity of removing superfluous or injured cells during normal development, tissue turn-over
and in response to damaging conditions. These finalised killings occur throughout a process, commonly called programmed cell
death (PCD), which is placed under strict cellular control. PCD is regulated by the products of the expression of a number of
genes. This fact raises the intriguing possibility of inhibiting such degenerative processes by operating on some of the controlling
genes. Central neurons of transgenic mice overexpressing bcl-2, a powerful inhibitor of PCD, are remarkably resistant to
degeneration induced by noxious stimuli. We have explored the fate of retinal ganglion cells and of their axons, when such
transgenic animals have been challenged by a lesion of the optic nerve. These results have direct bearing on the possibility of
attaining functional restoration of the injured pathway. © 1998 Elsevier Science Ltd. All rights reserved.
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1. Introduction
The optic nerve has been extensively used to study
the degenerative processes started by traumatic injury
in the central nervous system. This is so because the
optic nerve is rather easily accessible for surgical and
pharmacological manipulation and, at the same time,
the neurons originating its fibers, the retinal ganglion
cells (RGC), are readily recognisable. A traumatic in-
jury to the optic nerve induces the death of the vast
majority of the axotomised RGCs: the rapidity and
extent of this degenerative process depends critically on
the severity of the lesion, on its location along the nerve
[31] and on the age of the animal. Recently it has been
demonstrated that axotomy starts a process of pro-
grammed cell death (PCD) in the RGCs, as clearly
shown in retinae of new-borns where the signs of
apoptosis (the morphological correlate of PCD) become
manifest shortly after nerve section [27]. This demon-
stration is more difficult to attain in adult retinae,
because the death process is spread over a time window
of several weeks, and the telltale signs of apoptosis are
therefore rather elusive [3,15].
The discovery that programmed cell death is impli-
cated in axotomy-induced degeneration is very impor-
tant because PCD is a regulated process placed under
the control of a number of proteins [10,20,24]. There-
fore we might be able to inhibit the degenerative pro-
cess by fiddling with some of the regulatory or effector
stages. Among the regulatory elements of PCD, the
product of the expression of the gene bcl-2 is extremely
well maintained in evolution, and it plays a powerful
inhibitory role on the death process in organisms as
different as C. elegans and man [13]. In vitro studies
have shown that bcl-2 has a strong protective effect on
neurons when they are challenged by a great variety of
injuries, such as growth factor deprivation, hypoxia,
excitotoxicity, and so on [1,18,33]. This is a remarkable
and potentially useful fact, because it implies that the
pathways activated by these various injuries do, at least
to some extent, converge on some common executioner
mechanism, and that bcl-2 plays its inhibitory effect
enough downstream to act on all of these pathways.
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The protective action of this regulatory gene critically
depends on the level of its expression. However, it
seems that bcl-2 plays its role only during early devel-
opment, as a part of the regulatory machinery that
controls developmental cell death [17]. Later on in
development the physiological levels of bcl-2 expression
in the CNS are too low to prevent cell death induced by
noxious stimuli. In the past, the protective effects of
bcl-2 on central neurons have been studied in in vitro
systems where its level had been artificially raised [1,14].
Recently, Martinou and his associates generated a
transgenic mice by inserting in the progenitor genoma a
gene coding for human bcl-2 [11,23]. The transgene is
placed under the control of a neuron-specific enolase
and bcl-2 is overexpressed in most neurons of the CNS,
starting from embryonic day 13. In this review we
intend to show how powerful bcl-2 overexpression is in
inhibiting programmed cell death in the retina both
during development and following optic nerve injury.
2. Protection of axotomised ganglion cells
Development of the nervous system is accompanied
by a diffused process of cell death that is critical for
shaping the mature system. All classes of retinal neu-
rons are affected by this natural mortality and, in
particular, at least half of the ganglion cells in mice
retina die in the first few days of postnatal life. During
this time RGCs are extremely vulnerable to a section of
the optic nerve, and at least 50% of them die within 24
h from the lesion. The RGCs demise occurs because of
the activation of PCD, as demonstrated by the charac-
terisation of the dying neurons [27]. Twenty-four hours
after optic nerve transection, RGCs displayed all the
typical signs of apoptosis: nuclei were vesciculated with
highly condensed chromatin (pyknosis) and the DNA
showed a specific fragmentation pattern [12]. Perhaps
the most characteristic morphological sign of apoptosis
is the fragmentation of the cell in small vesicles which
are densely stained by a nuclear dye: Fig. 1B shows this
phenomenon in a neonatal wild-type retina 24 h after
intracranial section of the optic nerve. The retina of the
transgenic mice overexpressing bcl-2 was virtually nor-
mal 24 h after surgery (Fig. 1A).
Ganglion cell degeneration after optic nerve section
progresses much more slowly in the adult than in the
neonate. For this reason only a small fraction of cells
are pyknotic at any time after the section, and it is
therefore more difficult to characterise the death pro-
cess. However, the results we obtained in the immature
retinae led us to expect a comparable protective effect
of bcl-2 overexpression on the adult transgenic retina.
In Fig. 1, Panels D and F show retinae from a trans-
genic (D) and wild-type adult donors 3.5 and 2 months
after optic nerve section. The comparison of the two
panels clearly shows that cell death induced by axo-
tomy is markedly inhibited by the transgene overex-
pression. Another interesting fact is that the control
retina from the transgenic mouse has many more cells
than the wild-type retina (compare panels C and E in
Fig. 1). This is certainly due to the inhibitory effects of
bcl-2 overexpression on developmental cell death [4].
Our data on cell survival are summed up in Fig. 2.
RGCs are similarly numerous in both wild-type and
transgenic neonatal mice, but more than half of these
cells are lost due to natural cell death that occurs in
wild-type mice but not in the transgenic population.
For this reason, adult wild-type mice have about one-
third of the retinal ganglion cells of transgenic adult
mice.
Axotomy has a devastating effect on the immature
retina, while no significant loss occurs in the transgenic
animals at least in the first 24 h after lesion. When the
nerve section is performed in adult transgenic mice it
Fig. 1. Cell death in the ganglion cell layer in retinae of transgenic
and wild-type mice following optic nerve section. The panels on the
left (A,C,D) show retinae from bcl-2 overexpressing mice, while the
panels on the right (B,E,F) show retinae from wild-type mice. (A,B)
Retinae of neonatal mice 24 h after optic nerve cut; the arrow points
to an isolated pyknotic cell in the retina from the transgenic mouse.
Several degenerating cells are visible in the retina from the neonate.
(C,E) Retinae controlateral to the optic nerve lesion in adult mice.
RGC density is far less in the wild-type (E) than in the transgenic (C).
(D) Retina from a transgenic mice 3.5 months after optic nerve
transection: the comparison with the control field (C) shows only a
moderate cell loss. (F) Wild-type retina 2 months after the lesion:
most of the surviving cells are displaced amacrine cells. Calibration
bars: (A,B) 10 mm, (C–F) 20 mm. Retinae have been whole mounted
and stained with cresyl violet, all fields were chosen in the middle
peripheral retina.
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Fig. 2. Number of retinal ganglion cells in wild-type and transgenic
mice: dashed bars indicate countings from control retinae, filled bars
represent countings from retinae from the operated side. In each
panel, the label Newborn indicates data from P1–2 mice, 24 h after
section. The survival for the adult mice was 2 and 3.5 months for the
wild-type and transgenic animals, respectively. Countings have been
corrected for the population of displaced amacrine cells as explained
elsewhere [4,7]. Error bars indicate standard deviation, numbers in
parentheses indicate the number of retinae analysed in each group.
genic mice, up to the point that the centre–periphery
gradient was reverted. This observation might be ex-
plained by the following argument: Villegas-Pe´res et al.
[31] observed that RGC vulnerability to optic nerve
section was inversely proportional to the distance of the
lesion from the retina. In our conditions the section is
performed about 3 mm from the optic disk, therefore
peripheral neurons are twice as far from the section site
than neurons at the center of the retina [7].
3. Preservation of retinal function
We wondered whether the surviving cells were still
functionally connected to the incoming visually driven
synaptic input, and whether they had some residual
electrophysiological activity. Fig. 4 shows the elec-
troretinogram evoked by a patterned stimulation (P-
ERG), as measured by corneo-scleral electrodes placed
under the eyelids. A and B in Fig. 4 show the record-
ings from the control eye of a wild-type (A) and a
transgenic mouse (B) obtained 2 and 3.5 months, re-
spectively, after surgery. The wave form, which is
known to depend on the RGC electrical activity [22],
Fig. 3. Isodensity maps of all neurons in the ganglion cell layer of two
pairs of retinae, from transgenic (top pair) and wild-type mice
(bottom pair). The control retinae, controlateral to the lesioned optic
nerve, are shown on the left, while lesioned retinae 3.5 (top) and 2
months (bottom) after optic nerve transection are shown on the right.
The shift from one grey level to the adjacent indicates a 5% change in
cell density with respect to the peak density of the corresponding
unlesioned retina. Most of the cells seen in the wild-type retina after
section are displaced amacrine cells. The peak density of the trans-
genic and wild-type retinae were 16600 and 11600 cells:mm2, respec-
tively. The label N indicates the nasal quadrant of each retina. Dorsal
side is up. The calibration bar is 3 mm.
appears that bcl-2 protection is not complete, at least
when long post-surgical survivals are involved, since
30% of RGCs were found to be dead 3.5 months after
lesion. However, this mortality is vastly inferior to the
one observed in the wild-type animal, where 95% of
cells died in a period of 2 months after lesion [7].
It is interesting to look at the distribution of the
surviving neurons in the retina: Fig. 3 shows the iso-
density maps for the retinae from wild-type and trans-
genic mice. It is clear that the control transgenic retina
(upper left panel) displayed a much higher cell density
(see legend for numerical details) and that the center to
periphery gradient was less defined than in the wild-
type retina (lower left panel). After lesion of the optic
nerve, the wild-type retina appeared very depleted
(lower right panel), much more so than the retina from
the transgenic (upper right). The majority of cell loss
occurred in the central area of the retina of the trans-
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Fig. 4. Pattern electroretinogram evoked by alternating gratings of
0.1 c:degree recorded in wild-type (A) and transgenic mice (B). The
upper panels show the recordings from the control eye. The lower
panels show the recordings from the operated side. The dotted traces
are representative of the noise. Vertical calibration bar, 0.5 mV.
contrast with the situation usually met in the central
nervous system, where an almost complete loss of neu-
rons is the normal response to a traumatic injury. In
our view, the obvious question to ask at this point is: is
this system capable of regeneration at all? On one hand,
it is tempting to answer that, whatever intrinsic regener-
ative capability were present in central neurons, this
system should maximise the chances for regeneration,
since it is not limited by cell death. On the other hand,
it is clear that much more than survival is necessary for
regeneration.
Indeed the lack of regeneration in the mammalian
CNS is due to a combination of factors, most of them
still poorly understood, and not only to the high mor-
tality of the injured cells. A key element on the road to
regeneration is the modification of the environment
that has to be crossed by the regenerating fibers. This
case is clearly illustrated by a difficult experiment per-
formed by the group led by Albert Aguayo [30], where
they showed some regeneration toward target, once a
more permissive environment (peripheral nerve graft)
was offered to RGCs for their axons to grow. Therefore
it is certainly naive to expect major regeneration from
the bcl-2 system unless additional measures are taken to
confront the inhibitory characteristics of the environ-
ment. One class of inhibitory factors has been charac-
terised by Schwab and collaborators, who identified
myelin-associated proteins that, on binding with a re-
ceptor on the growth cones, inhibit the fiber elongation.
These proteins are thought to be the main inhibitory
factors present on the central myelin. The Swiss group
purified an antibody, named IN-1, that binds the in-
hibitory proteins and neutralises their effect [6]. In a
number of elegant in vivo and in vitro experiments, the
authors showed that this simple treatment makes the
central myelin far less inhibitory on regenerating fibers
[5,29,32].
The neutralising antibody is produced by a line of
hybridoma cells, that can be implanted in small con-
tainers placed nearby the lesioned nerves. Fig. 6A
shows a cross-section of one capsule filled with hybri-
doma cells that proliferated rapidly and invaded the
available volume. One problem of this strategy of im-
plant is that the antibodies are large molecules that
penetrate very little into the tissue. A potential solution
to this problem could be to transplant the hybridoma
cells directly into the nerve nearby the lesion site, as
shown in Fig. 6B. Further enhancement of the regener-
ative capabilities of the lesioned neurons could be ob-
tained by co-transplant of Schwann cells that are
known to produce a number of trophic factors, and to
participate in maintenance and repair in the peripheral
nervous system [9,25]. We are following all these av-
enues, but it is too early to tell how successful these
strategies will be.
appeared quite similar in the two control eyes. The
situation was drastically different in the eyes on the
operated side: the P-ERG of the bcl-2 retina was virtu-
ally identical to control, whereas the wild-type retina
was totally unresponsive [26].
These data show that bcl-2 overexpression protected
the cell body from degeneration, and that the dendrites
were, at least to some extent, still present and capable
of receiving and integrating synaptic inputs. Further-
more, the membrane properties must have been suffi-
ciently preserved in order to maintain the
electrophysiological activity. Therefore cell body and
dendritic arborisation of the injured neurons were rela-
tively unaffected by the lesion. But what about the
proximal segment of the sectioned axons? Fig. 5 shows
the appearance of the optic nerve nearby the emergence
from the eye, as seen by electron microscopy. The
wild-type nerve was clearly degenerated with only very
few surviving fibers, which were surrounded by degen-
erating myelinic sheaths. Most of the space previously
occupied by myelinated fibers has been invaded by
hypertrophic astrocytes. Once again, the situation was
much better in the stump of the transgenic nerve. There
was a large number of surviving fibers still sheeted in a
normally looking myelinic envelope. Gliosis appeared
to be much reduced if present at all [7].
4. Axonal regeneration
In summary, we have described a model where cen-
tral neurons survive for several months after axotomy,
they maintain functionality and connectivity, and at
least the proximal segment of their axons keeps a
relatively normal ultrastructure. This is in profound
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Fig. 5. Electron micrograph of the proximal stump of the optic nerve of a wild-type (A) and transgenic mouse (B). The survival times after surgery
were 2 and 3.5 months for (A) and (B), respectively. The star indicates an hypertrophic astrocytic process, and the arrowhead points to a large
diameter fiber surrounded by a degenerating myelinic sheet. The calibration bar is 1 mm. Methods as described by Cenni et al. [7].
Fig. 7 shows a transgenic nerve 3 months after the
crush and simultaneous implantation of a capsule
filled with hybridoma cells on the lesioned nerve (A).
Many surviving fibers can be seen sprouting nearby
the lesion site (C). Some fibers succeeded in escaping
from the crush site and reached the chiasm (B). Simi-
lar regenerating fibers have been found by Weibel et
al. [32], who crushed the optic nerve of young (P16–
18) rats and implanted encapsulated IN-1 hybridoma
cells over the lesioned nerve. However, our experi-
mental paradigm has important differences. We ob-
served regenerating fibers and vigorous sprouting a
long time after the lesion (over 3 months) in adult
mice. In the earlier experiment, much younger animals
were used (presumably because regeneration proceeds
more rapidly) and the RGCs had to be supplemented
by endogenous factors in order to keep them viable.
Such a treatment was not necessary in the bcl-2 over-
expressing mice. Nerves from similarly treated wild-
type donors failed to show significative regeneration.
Bcl-2 overexpression could have other actions on
regeneration beyond the effect due to the improved
survival of the injured neurons. Recent results suggest
that the Bcl-2 protein may play its protective role by
antagonising rises in cytosolic free calcium due to the
release from internal stores [16,21,28]. This may have
a direct bearing on the problem of regeneration, since
growth cone motility is known to depend critically on
Ca levels [19]. In addition, also the myelin inhibitory
action is mediated by calcium changes: contact of the
growth cone with the myelin inhibitory protein causes
a large Ca release from internal stores, and this event
is rapidly followed by the collapse of the growth cone
[2]. The prevention of calcium release, and the resul-
tant stabilisation of cytosolic calcium concentration,
was sufficient to prevent the collapse of the growth
cone. Therefore, it is quite conceivable that bcl-2
overexpression, acting on Ca homeostasis, might en-
hance the regenerative capabilities of the lesioned ax-
ons. Indeed, an in vitro experiment by Chen et al. [8]
demonstrated that neurons from bcl-2 overexpressing
donors grew a rich plexus of neurites on an embry-
onic tectum slice. When neurons from wild-type mice
were cultured in similar conditions, they failed to pro-
duce substantial outgrowth.
Fig. 6. (A) A cross-section of a capsule filled with hybridoma cells
stained with the vital fluorescent dye DiI. Calibration bar, 200 mm.
The inset shows the cells at higher magnification. (B) A lesioned nerve
5 days after injection of hybridoma cells in the nerve parenchyma
nearby the lesion site. Calibration bar, 200 mm.
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Fig. 7. Reconstruction of part of the optic nerve of a bcl-2 adult mouse 3 months after crush. Retinal ganglion cell axons, that appear black in
the figure, are traced by injecting Neurobiotin in the eye ipsilateral to the lesion 24 h before sacrifice. Some sprouting can be seen at the lesion
site (large arrow head), and this area is shown at a larger scale in (C). A small bundle of fibers pass the lesion and enter in the chiasm (small
arrowheads, enlarged in (B)). These fibers have the characteristic morphology of regenerating processes. Calibration bars are 200 and 100 mm in
(A) and (B,C), respectively. Neurobiotin has been revealed by incubation in fluorescein-conjugated avidin. Three contiguous fields have been
imaged at the confocal microscope by projecting six different focal planes for each field. The figure has been obtained by pasting together the three
fields.
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